APMD · Apnimed, Inc.
AI read · Good for APMD
The AI's read
That cash gives Apnimed room to prepare for a possible launch without needing more money right away. But the FDA has not approved the drug, and quarterly research and administrative costs rose. Those concerns temper the good news, but do not erase the support from its cash.